Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antihypertensive drug dihydropyridine calcium channel blocker |
| gptkbp:ATCCode |
C08CA13
|
| gptkbp:CASNumber |
86189-79-9
|
| gptkbp:developedBy |
gptkb:Japan
|
| gptkbp:drugBank_ID |
DB09219
|
| gptkbp:eliminationHalfLife |
5-7 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:hasMolecularFormula |
C18H20N2O6
|
| https://www.w3.org/2000/01/rdf-schema#label |
valdipine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
blocks L-type calcium channels
|
| gptkbp:meltingPoint |
116-118°C
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:proteinBinding |
93-95%
|
| gptkbp:PubChem_CID |
60722
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
edema
dizziness headache flushing |
| gptkbp:synonym |
7-(2,3-dimethoxypropyl)-3,5-dimethyl 2-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
valedipine |
| gptkbp:UNII |
6T6UO8363L
|
| gptkbp:usedFor |
treatment of hypertension
|
| gptkbp:bfsParent |
gptkb:Valdipino
|
| gptkbp:bfsLayer |
7
|